Sobi™ Satellite Symposium

Agenda

Welcome and introductions - Dr. Carpenedo

Real-world challenges in the care of adults with ITP - Dr. Carpenedo

Patient case 1: When, why, and how to treat after first-line - Dr. Lozano

Patient case 2: Facing a patient with refractory ITP – when, why, and how to treat - Dr. Ghanima

Closing remarks - Dr. Carpenedo

Publication
  • EHA •
  • 15 June, 2025 •
  • •

Economic Burden of Cytopenia in Patients with Myelofibrosis: Analysis of a US National Administrative Claims Database

Aaron T Gerds, Lucia Masarova, Nicole M Engel-Nitz, Michael Marrone, Jefferey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Lindsay AM Rein

Available materials

Poster
Publication
  • EHA •
  • 15 June, 2025 •
  • •

Real-world effectiveness of pacritinib in patients with myelofibrosis who have thrombocytopenia and anemia

Raajit Rampal, Samantha Eiffert, Michael Marrone, Lisa Morere, Abiola Oladapo, Anubhav Sharma, Purvi Suthar, Anupama Vasudevan, Michael Vredenburg , John Mascarenhas

Available materials

Poster
Publication
  • EHA •
  • 15 June, 2025 •
  • •

Real-World Treatment Patterns and Clinical Outcomes in Patients with Myelofibrosis Treated with Pacritinib (PAC) with platelets ≥50 x10^9/L at PAC initiation: Interim results from the MY-PAC Study

Doug Tremblay, Abiola Oladapo, Emily Levine, Michael Marrone, Djibril Liassou, Purvi Suthar, Adina Geprifti, Gerard Hoehn, Michael Vredenburg , Bruce Feinberg, Naveen Pemmaraju, James Rossetti

Available materials

Poster
Publication
  • JSH •
  • 10 October, 2025 •
  • •

One-year efficacy and safety of avatrombopag for chronic immune thrombocytopenia in Japanese adults

Hiroki Yamaguchi, Masaki Iino, Yoshiaki Tomiyama , Harumi Kamiya, Jessica Zhang, Nina Skuban

Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Real-World Outcomes of Avatrombopag Treatment in Primary ITP Stratified by Prior TPO-RA Exposure

Srikanth Nagalla, Moshe Y Levy, Shruti Chaturvedi, Scott Kolodny, Abiola Oladapo, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Loren Ormenaj, Sinia Sareen, Michael Vredenburg

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Analysis of Baseline Influences on Platelet Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Pati

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster
Publication
  • ISTH •
  • 22 June, 2025 •
  • •

Evaluation of Efficacy and Safety of Avatrombopag in Children with ITP Based on Disease Duration

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster
Sign up for alerts